Loss of parental-specific methylation at the IGF2 locus in human hepatocellular carcinoma

Journal of Pathology

Volumn 201, Issue 3, 2003, Pages 473-479

  Poirier, Karine ^a   Chalas, Céline ^a   Tissier, Frédérique ^a   Couvert, Philippe ^a   Mallet, Vincent ^a   Carrié, Alain ^a   Marchio, Agnès ^b   Sarli, Dario ^c   Gicquel, Christine ^d   Chaussade, Stanislas ^e   Beljord, Cherif ^a   Chelly, Jamel ^a   Kerjean, Antoine ^a   Terris, Benoit ^e  

^a INSTITUT COCHIN   (France)

^b INSTITUT PASTEUR   (France)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d ARMAND TROUSSEAU HOSPITAL   (France)

^e Institut Cochin   (France)

Author keywords

Bisulphite; DHPLC; Hepatocellular carcinoma; IGF2; Imprinting; Methylation

Indexed keywords

SOMATOMEDIN B; TRANSCRIPTION FACTOR;

ARTICLE; CHROMOSOME 11P; CONTROLLED STUDY; GENE LOCUS; GENOME IMPRINTING; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN METHYLATION; PROTEIN SYNTHESIS; VIRUS HEPATITIS;

CARCINOMA, HEPATOCELLULAR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMOSOMES, HUMAN, PAIR 11; DNA, NEOPLASM; GENE EXPRESSION; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LIVER NEOPLASMS; MEMBRANE PROTEINS; METHYLATION; POLYMERASE CHAIN REACTION; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 0242643603     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1477     Document Type: Article

References (31)

1. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nature Genet 2002; 31: 339-346.
2. Reik W, Walter J. Genomic imprinting: parental influence on the genome. Nature Genet Rev 2001; 2: 21-32.
3. Falls JG, Pulford DJ, Wylie AA, Jirtle RL. Genomic imprinting: implications for human disease. Am J Pathol 1999; 154: 635-647.
4. Feinberg A, Cui H, Ohlsson R. DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. Semin Cancer Biol 2002; 12: 389.
5. Jirtle RL, Sander M, Barrett JC. Genomic imprinting and environmental disease susceptibility. Environ Health Perspect 2000; 108: 271-278.
6. De Souza AT, Hankins GR, Washington MK, et al. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene 1995; 10: 1725-1729.
7. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genet 1995; 11: 447-449.
8. Yamada T, De Souza AT, Finkelstein S, Jirtle RL. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci U S A 1997; 94: 10 351-10 355.
9. Piao Z, Choi Y, Park C, et al. Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma. Cancer Lett 1997; 120: 39-43.
10. Schwienbacher C, Gramantieri L, Scelfo R, et al. Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas. Proc Natl Acad Sci U S A 2000; 97: 5445-5449.
11. Scelfo RA, Schwienbacher C, Veronese A, et al. Loss of methylation at chromosome 11p15.5 is common in human adult tumors. Oncogene 2002; 21: 2564-2572.
12. Engel JR, Smallwood A, Harper A, et al. Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. J Med Genet 2000; 37: 921-926.
13. Kim KS, Lee YI. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Cancer Lett 1997; 119: 143-148.
14. Li X, Nong Z, Ekstrom C, et al. Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma. Cancer Res 1997; 57: 2048-2054.
15. Uchida K, Kondo M, Takeda S, et al. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma. Mol Carcinog 1997; 18: 193-198.
16. Iizuka N, Oka M, Yamada-Okabe H, et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 2002; 62: 3939-3944.
17. Sohda T, Yun K, Iwata K, Soejima H, Okumura M. Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level. Lab Invest 1996; 75: 307-311.
18. Nardone G, Romano M, Calabro A, et al. Activation of fetal promoters of insulin-like growth factor II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Hepatology 1996; 23: 1304-1312.
19. Sohda T, Iwata K, Soejima H, et al. In situ detection of insulin-like growth factor II (IGF2) and H19 gene expression in hepatocellular carcinoma. J Hum Genet 1998; 43: 49-53.
20. Kerjean A, Vieillefond A, Thiounn N, et al. Bisulfite genomic sequencing of microdissected cells. Nucleic Acids Res 2001; 29: e106.
21. Couvert P, Poirier K, Carrié A, et al. A DHPLC-based method for DNA methylation analysis of differential methylated regions from imprinted genes. BioTechniques 2003; 34: 356-362.
22. Gicquel C, Raffin-Sanson ML, Gaston V, et al. Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. J Clin Endocrinol Metab 1997; 82: 2559-2565.
23. Takeda S, Kondo M, Kumada T, et al. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease. Oncogene 1996; 12: 1589-1592.
24. Harris TM, Rogler LE, Rogler CE. Reactivation of the maternally imprinted IGF2 allele in TGFalpha induced hepatocellular carcinomas in mice. Oncogene 1998; 16: 203-209.
25. Yao X, Hu J, Daniels M, et al. A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma. J Clin Invest 2003; 111: 265-273.
26. Vernucci M, Cerrato F, Besnard N, et al. The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis. Oncogene 2000; 19: 6376-6385.
27. Cui H, Onyango P, Brandenburg S, et al. Loss of imprinting in colorectal Cancer linked to hypomethylation of H19 and IGF2. Cancer Res 2002; 62: 6442-6446.
28. Cui H, Cruz-Correa M, Giardiello FM, et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003; 299: 1753-1755.
29. Paulsen M, El-Maarri O, Engemann S, et al. Sequence conservation and variability of imprinting in the Beckwith-Wiedemann syndrome gene cluster in human and mouse. Hum Mol Genet 2000; 9: 1829-1841.
30. Kanduri C, Pant V, Loukinov D, et al. Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive. Curr Biol 2000; 10: 853-856.
31. Kanduri C, Fitzpatrick G, Mukhopadhyay R, et al. A differentially methylated imprinting control region within the Kcnq1 locus harbors a methylation-sensitive chromatin insulator. J Biol Chem 2002; 277: 18 106-18 110.